Sara P. Kubek

发表

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Paul S Mischel, Steve Horvath, Timothy F Cloughesy, 2012, Cancer discovery.

Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy

S. Heimfeld, H. Kiem, G. Trobridge, 2016, Nature Communications.

Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus

H. Kiem, C. Peterson, P. Becker, 2020, Molecular therapy. Methods & clinical development.

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Russell G. Jones, M. Birnbaum, C. Thompson, 2005, Molecular cell.

Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations

H. Kiem, R. Shahbazi, Kevin G. Haworth, 2019, Nature Materials.

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

R. Beroukhim, C. Brennan, T. Cloughesy, 2009, Cancer cell.

The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis.

Russell G. Jones, M. Bootman, C. Thompson, 2007, Immunity.

The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation

Paul S Mischel, Ivan Dikic, Timothy F Cloughesy, 2010, Proceedings of the National Academy of Sciences.

Hematopoietic Stem Cell Approaches to Cancer.

H. Kiem, J. Adair, Sara P. Kubek, 2017, Hematology/oncology clinics of North America.

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

R. Beroukhim, C. Brennan, T. Cloughesy, 2009, Cancer cell.